Skip to main content

Table 2 Outcome data of RCTs included in the meta-analysis of statin for infection and sepsis

From: Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies

Study/year

Mean age (y) statin/ non-statin (mean ± SD)

Male sex (%) statin/non-statin

Need for MV or ICU admission

Severity of illness statin/non-statin (mean ± SD)

Mortality statin/non-statin

Length of hospital stay statin/non-statin

New development of severe sepsis

     

In-hospital mortality

28-day mortality

  

Novak V et al.[17]/2009

66.0 ± 17.2/72.7 ± 13.8

35.7/39.0

3/42 vs 5/41

APACHE II score (11.2 ± 4.3/8.9 ± 4.8)

0/42 vs 0/41

NA

4 days (IQR 3 to 6)/4 days (IQR 2 to 6)

2/42 vs 2/41

Kruger PS et al.[18]/2011

68.2 ± 12.7/68.5 ± 11.9

64.0/65.0

13/75 vs 11/75

NA

6/75 vs 4/75

NA

7 days (IQR 4 to 12)/6 days (IQR 4 to 11)

NA

Patel JM et al.[19]/2012

62.8 ± 21.2/64.0 ± 15.6

51.0/51.0

0/49 vs 2/51

APACHE II score (11.8 ± 5.6/11.9 ± 6.0)

NA

2/49 vs 2/51

5 days (IQR 3 to 13)/6 days (IQR 4 to 12)

2/49 vs 12/51

Kruger P et al.[20]/2013

58 (44 to 67)/64 (50 to 75)*

59.0 /65.0

123/123 vs 127/127

APACHE II score (22.1 ± 7.7/23.5 ± 7.8)

16/123 vs 23/127

12/123 vs 22/127

18.3 days (IQR 11.0 to 38.7)/22.7 days (IQR 12.4 to 37.0)

NA

Papazian L et al.[21]/2013

60.0 ± 16.0/59.0 ± 17.0

73.0/77.0

146/146 vs 138/138

SOFA score (7.2 ± 3.6/6.7 ± 2.9)

43/146 vs 38/138

31/146 vs 21/138

37 days (IQR 21 to 59)/35 days (IQR 22 to 62)

NA

  1. *Data were shown as median (IQR). APACHE II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive care unit; IQR, interquartile range; SOFA, sepsis-related organ failure assessment.